The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 14, 2012
Filed:
Jun. 26, 2007
Rikki Peter Alexander, Slough, GB;
Pavandeep Singh Aujla, Slough, GB;
Karen Viviane Lucile Crépy, Slough, GB;
Anne Marie Foley, Slough, GB;
Richard Jeremy Franklin, Slough, GB;
Alan Findlay Haughan, Slough, GB;
Helen Tracey Horsley, Slough, GB;
William Mark Jones, Slough, GB;
Bénédicte Irma Léonce Frédérique Lallemand, Brussels, BE;
Stephen Robert Mack, Slough, GB;
Trevor Morgan, Slough, GB;
Patrick Marie Ghislain Pasau, Brussels, BE;
David Jonathan Phillips, High Peak, GB;
Verity Margaret Sabin, Slough, GB;
George Martin Buckley, Slough, GB;
Kerry Jenkins, Slough, GB;
Benjamin Garfield Perry, Slough, GB;
Rikki Peter Alexander, Slough, GB;
Pavandeep Singh Aujla, Slough, GB;
Karen Viviane Lucile Crépy, Slough, GB;
Anne Marie Foley, Slough, GB;
Richard Jeremy Franklin, Slough, GB;
Alan Findlay Haughan, Slough, GB;
Helen Tracey Horsley, Slough, GB;
William Mark Jones, Slough, GB;
Bénédicte Irma Léonce Frédérique Lallemand, Brussels, BE;
Stephen Robert Mack, Slough, GB;
Trevor Morgan, Slough, GB;
Patrick Marie Ghislain Pasau, Brussels, BE;
David Jonathan Phillips, High Peak, GB;
Verity Margaret Sabin, Slough, GB;
George Martin Buckley, Slough, GB;
Kerry Jenkins, Slough, GB;
Benjamin Garfield Perry, Slough, GB;
UCB Pharma S.A., Brussels, BE;
Abstract
A series of 6,7-dihydro[1,3]thiazolo[5,4-c]pyridin-4(5H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.